32 results on '"Ong, Edison"'
Search Results
2. A comprehensive update on CIDO: the community-based coronavirus infectious disease ontology
- Author
-
He, Yongqun, Yu, Hong, Huffman, Anthony, Lin, Asiyah Yu, Natale, Darren A., Beverley, John, Zheng, Ling, Perl, Yehoshua, Wang, Zhigang, Liu, Yingtong, Ong, Edison, Wang, Yang, Huang, Philip, Tran, Long, Du, Jinyang, Shah, Zalan, Shah, Easheta, Desai, Roshan, Huang, Hsin-hui, Tian, Yujia, Merrell, Eric, Duncan, William D., Arabandi, Sivaram, Schriml, Lynn M., Zheng, Jie, Masci, Anna Maria, Wang, Liwei, Liu, Hongfang, Smaili, Fatima Zohra, Hoehndorf, Robert, Pendlington, Zoë May, Roncaglia, Paola, Ye, Xianwei, Xie, Jiangan, Tang, Yi-Wei, Yang, Xiaolin, Peng, Suyuan, Zhang, Luxia, Chen, Luonan, Hur, Junguk, Omenn, Gilbert S., Athey, Brian, and Smith, Barry
- Published
- 2022
- Full Text
- View/download PDF
3. Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
- Author
-
Ong, Edison, Huang, Xiaoqiang, Pearce, Robin, Zhang, Yang, and He, Yongqun
- Published
- 2021
- Full Text
- View/download PDF
4. CanVaxKB: a web-based cancer vaccine knowledgebase.
- Author
-
Asfaw, Eliyas, Lin, Asiyah Yu, Huffman, Anthony, Li, Siqi, George, Madison, Darancou, Chloe, Kalter, Madison, Wehbi, Nader, Bartels, Davis, Fleck, Elyse, Tran, Nancy, Faghihnia, Daniel, Berke, Kimberly, Sutariya, Ronak, Reyal, Farah, Tammam, Youssef, Zhao, Bin, Ong, Edison, Xiang, Zuoshuang, and He, Virginia
- Published
- 2024
- Full Text
- View/download PDF
5. ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions
- Author
-
Yu, Hong, Nysak, Solomiya, Garg, Noemi, Ong, Edison, Ye, Xianwei, Zhang, Xiangyan, and He, Yongqun
- Published
- 2019
- Full Text
- View/download PDF
6. OSCI: standardized stem cell ontology representation and use cases for stem cell investigation
- Author
-
He, Yongqun, Duncan, William D., Cooper, Daniel J., Hansen, Jens, Iyengar, Ravi, Ong, Edison, Walker, Kendal, Tibi, Omar, Smith, Sam, Serra, Lucas M., Zheng, Jie, Sarntivijai, Sirarat, Schürer, Stephan, O’Shea, K. Sue, and Diehl, Alexander D.
- Published
- 2019
- Full Text
- View/download PDF
7. The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains.
- Author
-
Sacconnay, Lionel, De Smedt, Jonathan, Rocha-Perugini, Vera, Ong, Edison, Mascolo, Romuald, Atas, Anne, Vanden Abeele, Carline, de Heusch, Magali, De Schrevel, Nathalie, David, Marie-Pierre, Bouzya, Badiaa, Stobbelaar, Kim, Vanloubbeeck, Yannick, Delputte, Peter L., Mallett, Corey P., Dezutter, Nancy, and Warter, Lucile
- Subjects
RESPIRATORY syncytial virus ,RESPIRATORY syncytial virus infections ,RESPIRATORY syncytial virus infection vaccines ,OLDER people ,RESPIRATORY diseases - Abstract
The RSVPreF3-AS01 vaccine, containing the respiratory syncytial virus (RSV) prefusion F protein and the AS01 adjuvant, was previously shown to boost neutralization responses against historical RSV strains and to be efficacious in preventing RSV-associated lower respiratory tract diseases in older adults. Although RSV F is highly conserved, variation does exist between strains. Here, we characterized variations in the major viral antigenic sites among contemporary RSV sequences when compared with RSVPreF3 and showed that, in older adults, RSVPreF3-AS01 broadly boosts neutralization responses against currently dominant and antigenically distant RSV strains. RSV-neutralizing responses are thought to play a central role in preventing RSV infection. Therefore, the breadth of RSVPreF3-AS01–elicited neutralization responses may contribute to vaccine efficacy against contemporary RSV strains and those that may emerge in the future. Editor's summary: All viruses mutate, albeit at different rates, and respiratory syncytial virus (RSV) is no exception. Although the fusion (F) protein of RSV is more highly conserved than that other respiratory viruses, there is some variation in the F protein that could impact efficacy of RSV vaccines. Here, Sacconnay et al. found that immunization with the recently approved RSVPreF3 vaccine, particularly when administered with an adjuvant, elicited broad neutralizing antibody responses against currently dominant and antigenically distant strains of RSV in mice, cows, and older adults. Because RSV-neutralizing antibodies are considered key for protection against disease, these findings suggest that RSVPreF3 adjuvanted with AS01 should confer protection against currently circulating RSV strains and potentially against future variants. —Courtney Malo [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. A new framework for hostpathogen interaction research.
- Author
-
Hong Yu, Li Li, Huffman, Anthony, Beverley, John, Hur, Junguk, Merrell, Eric, Hsin-hui Huang, Yang Wang, Yingtong Liu, Ong, Edison, Liang Cheng, Tao Zeng, Jingsong Zhang, Pengpai Li, Zhiping Liu, Zhigang Wang, Xiangyan Zhang, Xianwei Ye, Handelman, Samuel K., and Sexton, Jonathan
- Subjects
DRUG design ,COVID-19 ,COMMUNICABLE diseases ,PROTEIN-protein interactions - Abstract
COVID-19 often manifests with different outcomes in different patients, highlighting the complexity of the host-pathogen interactions involved in manifestations of the disease at the molecular and cellular levels. In this paper, we propose a set of postulates and a framework for systematically understanding complex molecular host-pathogen interaction networks. Specifically, we first propose four host-pathogen interaction (HPI) postulates as the basis for understanding molecular and cellular host-pathogen interactions and their relations to disease outcomes. These four postulates cover the evolutionary dispositions involved in HPIs, the dynamic nature of HPI outcomes, roles that HPI components may occupy leading to such outcomes, and HPI checkpoints that are critical for specific disease outcomes. Based on these postulates, an HPI Postulate and Ontology (HPIPO) framework is proposed to apply interoperable ontologies to systematically model and represent various granular details and knowledge within the scope of the HPI postulates, in a way that will support AI-ready data standardization, sharing, integration, and analysis. As a demonstration, the HPI postulates and the HPIPO framework were applied to study COVID-19 with the Coronavirus Infectious Disease Ontology (CIDO), leading to a novel approach to rational design of drug/vaccine cocktails aimed at interrupting processes occurring at critical host-coronavirus interaction checkpoints. Furthermore, the host-coronavirus protein-protein interactions (PPIs) relevant to COVID-19 were predicted and evaluated based on prior knowledge of curated PPIs and domain-domain interactions, and how such studies can be further explored with the HPI postulates and the HPIPO framework is discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. COVID-19 vaccine design using reverse and structural vaccinology, ontology-based literature mining and machine learning.
- Author
-
Huffman, Anthony, Ong, Edison, Hur, Junguk, D'Mello, Adonis, Tettelin, Hervé, and He, Yongqun
- Subjects
- *
COVID-19 vaccines , *VACCINATION complications , *COVID-19 , *VACCINE safety , *STRUCTURAL engineering , *MACHINE learning - Abstract
Rational vaccine design, especially vaccine antigen identification and optimization, is critical to successful and efficient vaccine development against various infectious diseases including coronavirus disease 2019 (COVID-19). In general, computational vaccine design includes three major stages: (i) identification and annotation of experimentally verified gold standard protective antigens through literature mining, (ii) rational vaccine design using reverse vaccinology (RV) and structural vaccinology (SV) and (iii) post-licensure vaccine success and adverse event surveillance and its usage for vaccine design. Protegen is a database of experimentally verified protective antigens, which can be used as gold standard data for rational vaccine design. RV predicts protective antigen targets primarily from genome sequence analysis. SV refines antigens through structural engineering. Recently, RV and SV approaches, with the support of various machine learning methods, have been applied to COVID-19 vaccine design. The analysis of post-licensure vaccine adverse event report data also provides valuable results in terms of vaccine safety and how vaccines should be used or paused. Ontology standardizes and incorporates heterogeneous data and knowledge in a human- and computer-interpretable manner, further supporting machine learning and vaccine design. Future directions on rational vaccine design are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Vaxign2: the second generation of the first Web-based vaccine design program using reverse vaccinology and machine learning.
- Author
-
Ong, Edison, Cooke, Michael F, Huffman, Anthony, Xiang, Zuoshuang, Wong, Mei U, Wang, Haihe, Seetharaman, Meenakshi, Valdez, Ninotchka, and He, Yongqun
- Published
- 2021
- Full Text
- View/download PDF
11. VaximmutorDB: A Web-Based Vaccine Immune Factor Database and Its Application for Understanding Vaccine-Induced Immune Mechanisms.
- Author
-
Berke, Kimberly, Sun, Peter, Ong, Edison, Sanati, Nasim, Huffman, Anthony, Brunson, Timothy, Loney, Fred, Ostrow, Joseph, Racz, Rebecca, Zhao, Bin, Xiang, Zuoshuang, Masci, Anna Maria, Zheng, Jie, Wu, Guanming, and He, Yongqun
- Subjects
YELLOW fever ,VACCINES ,INFLUENZA vaccines ,CELL anatomy ,DATABASES - Abstract
Vaccines stimulate various immune factors critical to protective immune responses. However, a comprehensive picture of vaccine-induced immune factors and pathways have not been systematically collected and analyzed. To address this issue, we developed VaximmutorDB, a web-based database system of vaccine immune factors (abbreviated as "vaximmutors") manually curated from peer-reviewed articles. VaximmutorDB currently stores 1,740 vaccine immune factors from 13 host species (e.g., human, mouse, and pig). These vaximmutors were induced by 154 vaccines for 46 pathogens. Top 10 vaximmutors include three antibodies (IgG, IgG2a and IgG1), Th1 immune factors (IFN-γ and IL-2), Th2 immune factors (IL-4 and IL-6), TNF-α, CASP-1, and TLR8. Many enriched host processes (e.g., stimulatory C-type lectin receptor signaling pathway, SRP-dependent cotranslational protein targeting to membrane) and cellular components (e.g., extracellular exosome, nucleoplasm) by all the vaximmutors were identified. Using influenza as a model, live attenuated and killed inactivated influenza vaccines stimulate many shared pathways such as signaling of many interleukins (including IL-1, IL-4, IL-6, IL-13, IL-20, and IL-27), interferon signaling, MARK1 activation, and neutrophil degranulation. However, they also present their unique response patterns. While live attenuated influenza vaccine FluMist induced significant signal transduction responses, killed inactivated influenza vaccine Fluarix induced significant metabolism of protein responses. Two different Yellow Fever vaccine (YF-Vax) studies resulted in overlapping gene lists; however, they shared more portions of pathways than gene lists. Interestingly, live attenuated YF-Vax simulates significant metabolism of protein responses, which was similar to the pattern induced by killed inactivated Fluarix. A user-friendly web interface was generated to access, browse and search the VaximmutorDB database information. As the first web-based database of vaccine immune factors, VaximmutorDB provides systematical collection, standardization, storage, and analysis of experimentally verified vaccine immune factors, supporting better understanding of protective vaccine immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Reverse Microbiomics: A New Reverse Dysbiosis Analysis Strategy and Its Usage in Prediction of Autoantigens and Virulent Factors in Dysbiotic Gut Microbiomes From Rheumatoid Arthritis Patients.
- Author
-
Wang, Haihe, Ong, Edison, Kao, John Y., Sun, Duxin, and He, Yongqun
- Subjects
RHEUMATOID arthritis ,ATP-binding cassette transporters ,AUTOANTIGENS ,BIFIDOBACTERIUM bifidum ,GUT microbiome ,BIFIDOBACTERIUM - Abstract
Alterations in the gut microbiome have been associated with various human diseases. Most existing gut microbiome studies stopped at the stage of identifying microbial alterations between diseased or healthy conditions. As inspired by reverse vaccinology (RV), we developed a new strategy called Reverse Microbiomics (RM) that turns this process around: based on the identified microbial alternations, reverse-predicting the molecular mechanisms underlying the disease and microbial alternations. Our RM methodology starts by identifying significantly altered microbiota profiles, performing bioinformatics analysis on the proteomes of the microbiota identified, and finally predicting potential virulence or protective factors relevant to a microbiome-associated disease. As a use case study, this reverse methodology was applied to study the molecular pathogenesis of rheumatoid arthritis (RA), a common autoimmune and inflammatory disease. Those bacteria differentially associated with RA were first identified and annotated from published data and then modeled and classified using the Ontology of Host-Microbiome Interactions (OHMI). Our study identified 14 species increased and 9 species depleted in the gut microbiota of RA patients. Vaxign was used to comparatively analyze 15 genome sequences of the two pairs of species: Gram-negative Prevotella copri (increased) and Prevotella histicola (depleted), as well as Gram-positive Bifidobacterium dentium (increased) and Bifidobacterium bifidum (depleted). In total, 21 auto-antigens were predicted to be related to RA, and five of them were previously reported to be associated with RA with experimental evidence. Furthermore, we identified 94 potential adhesive virulence factors including 24 microbial ABC transporters. While eukaryotic ABC transporters are key RA diagnosis markers and drug targets, we identified, for the first-time, RA-associated microbial ABC transporters and provided a novel hypothesis of RA pathogenesis. Our study showed that RM, by broadening the scope of RV, is a novel and effective strategy to study from bacterial level to molecular level factors and gain further insight into how these factors possibly contribute to the development of microbial alterations under specific diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Modelling kidney disease using ontology: insights from the Kidney Precision Medicine Project.
- Author
-
Ong, Edison, Wang, Lucy L., Schaub, Jennifer, O'Toole, John F., Steck, Becky, Rosenberg, Avi Z., Dowd, Frederick, Hansen, Jens, Barisoni, Laura, Jain, Sanjay, de Boer, Ian H., Valerius, M. Todd, Waikar, Sushrut S., Park, Christopher, Crawford, Dana C., Alexandrov, Theodore, Anderton, Christopher R., Stoeckert, Christian, Weng, Chunhua, and Diehl, Alexander D.
- Subjects
- *
INDIVIDUALIZED medicine , *KIDNEY diseases , *MEDICAL sciences , *KIDNEY development , *KIDNEYS - Abstract
An important need exists to better understand and stratify kidney disease according to its underlying pathophysiology in order to develop more precise and effective therapeutic agents. National collaborative efforts such as the Kidney Precision Medicine Project are working towards this goal through the collection and integration of large, disparate clinical, biological and imaging data from patients with kidney disease. Ontologies are powerful tools that facilitate these efforts by enabling researchers to organize and make sense of different data elements and the relationships between them. Ontologies are critical to support the types of big data analysis necessary for kidney precision medicine, where heterogeneous clinical, imaging and biopsy data from diverse sources must be combined to define a patient's phenotype. The development of two new ontologies - the Kidney Tissue Atlas Ontology and the Ontology of Precision Medicine and Investigation - will support the creation of the Kidney Tissue Atlas, which aims to provide a comprehensive molecular, cellular and anatomical map of the kidney. These ontologies will improve the annotation of kidney-relevant data, and eventually lead to new definitions of kidney disease in support of precision medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.
- Author
-
Ong, Edison, Wong, Mei U, Huffman, Anthony, and He, Yongqun
- Abstract
To ultimately combat the emerging COVID-19 pandemic, it is desired to develop an effective and safe vaccine against this highly contagious disease caused by the SARS-CoV-2 coronavirus. Our literature and clinical trial survey showed that the whole virus, as well as the spike (S) protein, nucleocapsid (N) protein, and membrane (M) protein, have been tested for vaccine development against SARS and MERS. However, these vaccine candidates might lack the induction of complete protection and have safety concerns. We then applied the Vaxign and the newly developed machine learning-based Vaxign-ML reverse vaccinology tools to predict COVID-19 vaccine candidates. Our Vaxign analysis found that the SARS-CoV-2 N protein sequence is conserved with SARS-CoV and MERS-CoV but not from the other four human coronaviruses causing mild symptoms. By investigating the entire proteome of SARS-CoV-2, six proteins, including the S protein and five non-structural proteins (nsp3, 3CL-pro, and nsp8-10), were predicted to be adhesins, which are crucial to the viral adhering and host invasion. The S, nsp3, and nsp8 proteins were also predicted by Vaxign-ML to induce high protective antigenicity. Besides the commonly used S protein, the nsp3 protein has not been tested in any coronavirus vaccine studies and was selected for further investigation. The nsp3 was found to be more conserved among SARS-CoV-2, SARS-CoV, and MERS-CoV than among 15 coronaviruses infecting human and other animals. The protein was also predicted to contain promiscuous MHC-I and MHC-II T-cell epitopes, and the predicted linear B-cell epitopes were found to be localized on the surface of the protein. Our predicted vaccine targets have the potential for effective and safe COVID-19 vaccine development. We also propose that an "Sp/Nsp cocktail vaccine" containing a structural protein(s) (Sp) and a non-structural protein(s) (Nsp) would stimulate effective complementary immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
15. Improvement in the Analysis of Vaccine Adverse Event Reporting System Database.
- Author
-
Zhao, Lili, Lee, Sunghun, Li, Rongxia, Ong, Edison, He, Yongqun, and Freed, Gary
- Published
- 2020
- Full Text
- View/download PDF
16. CIDO, a community-based ontology for coronavirus disease knowledge and data integration, sharing, and analysis.
- Author
-
He, Yongqun, Yu, Hong, Ong, Edison, Wang, Yang, Liu, Yingtong, Huffman, Anthony, Huang, Hsin-hui, Beverley, John, Hur, Junguk, Yang, Xiaolin, Chen, Luonan, Omenn, Gilbert S., Athey, Brian, and Smith, Barry
- Subjects
COVID-19 pandemic ,DATA integration ,INFORMATION sharing ,DATA analysis ,STANDARDIZATION - Abstract
The Coronavirus Infectious Disease Ontology (CIDO) is a community-based ontology that supports coronavirus disease knowledge and data standardization, integration, sharing, and analysis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. Vaxign-ML: supervised machine learning reverse vaccinology model for improved prediction of bacterial protective antigens.
- Author
-
Ong, Edison, Wang, Haihe, Wong, Mei U, Seetharaman, Meenakshi, Valdez, Ninotchka, and He, Yongqun
- Subjects
- *
BACTERIAL antigens , *SUPERVISED learning , *MACHINE learning , *INTERNET servers , *PREDICTION models , *SOURCE code - Abstract
Motivation Reverse vaccinology (RV) is a milestone in rational vaccine design, and machine learning (ML) has been applied to enhance the accuracy of RV prediction. However, ML-based RV still faces challenges in prediction accuracy and program accessibility. Results This study presents Vaxign-ML, a supervised ML classification to predict bacterial protective antigens (BPAgs). To identify the best ML method with optimized conditions, five ML methods were tested with biological and physiochemical features extracted from well-defined training data. Nested 5-fold cross-validation and leave-one-pathogen-out validation were used to ensure unbiased performance assessment and the capability to predict vaccine candidates against a new emerging pathogen. The best performing model (eXtreme Gradient Boosting) was compared to three publicly available programs (Vaxign, VaxiJen, and Antigenic), one SVM-based method, and one epitope-based method using a high-quality benchmark dataset. Vaxign-ML showed superior performance in predicting BPAgs. Vaxign-ML is hosted in a publicly accessible web server and a standalone version is also available. Availability and implementation Vaxign-ML website at http://www.violinet.org/vaxign/vaxign-ml , Docker standalone Vaxign-ML available at https://hub.docker.com/r/e4ong1031/vaxign-ml and source code is available at https://github.com/VIOLINet/Vaxign-ML-docker. Supplementary information Supplementary data are available at Bioinformatics online. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. VIO: ontology classification and study of vaccine responses given various experimental and analytical conditions.
- Author
-
Ong, Edison, Sun, Peter, Berke, Kimberly, Zheng, Jie, Wu, Guanming, and He, Yongqun
- Subjects
- *
VACCINE effectiveness , *ONTOLOGIES (Information retrieval) , *YELLOW fever , *GENE expression profiling , *COMPUTER software , *ELECTRONIC data processing - Abstract
Background: Different human responses to the same vaccine were frequently observed. For example, independent studies identified overlapping but different transcriptomic gene expression profiles in Yellow Fever vaccine 17D (YF-17D) immunized human subjects. Different experimental and analysis conditions were likely contributed to the observed differences. To investigate this issue, we developed a Vaccine Investigation Ontology (VIO), and applied VIO to classify the different variables and relations among these variables systematically. We then evaluated whether the ontological VIO modeling and VIO-based statistical analysis would contribute to the enhanced vaccine investigation studies and a better understanding of vaccine response mechanisms. Results: Our VIO modeling identified many variables related to data processing and analysis such as normalization method, cut-off criteria, software settings including software version. The datasets from two previous studies on human responses to YF-17D vaccine, reported by Gaucher et al. (2008) and Querec et al. (2009), were re-analyzed. We first applied the same LIMMA statistical method to re-analyze the Gaucher data set and identified a big difference in terms of significantly differentiated gene lists compared to the original study. The different results were likely due to the LIMMA version and software package differences. Our second study re-analyzed both Gaucher and Querec data sets but with the same data processing and analysis pipeline. Significant differences in differential gene lists were also identified. In both studies, we found that Gene Ontology (GO) enrichment results had more overlapping than the gene lists and enriched pathway lists. The visualization of the identified GO hierarchical structures among the enriched GO terms and their associated ancestor terms using GOfox allowed us to find more associations among enriched but often different GO terms, demonstrating the usage of GO hierarchical relations enhance data analysis. Conclusions: The ontology-based analysis framework supports standardized representation, integration, and analysis of heterogeneous data of host responses to vaccines. Our study also showed that differences in specific variables might explain different results drawn from similar studies. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
19. Victors: a web-based knowledge base of virulence factors in human and animal pathogens.
- Author
-
Sayers, Samantha, Li, Li, Ong, Edison, Deng, Shunzhou, Fu, Guanghua, Lin, Yu, Yang, Brian, Zhang, Shelley, Fa, Zhenzong, Zhao, Bin, Xiang, Zuoshuang, Li, Yongqing, Zhao, Xing-Ming, Olszewski, Michal A, Chen, Luonan, and He, Yongqun
- Published
- 2019
- Full Text
- View/download PDF
20. The eXtensible ontology development (XOD) principles and tool implementation to support ontology interoperability.
- Author
-
He, Yongqun, Xiang, Zuoshuang, Zheng, Jie, Lin, Yu, Overton, James A., and Ong, Edison
- Subjects
INTERNETWORKING ,ONTOLOGIES (Information retrieval) - Abstract
Ontologies are critical to data/metadata and knowledge standardization, sharing, and analysis. With hundreds of biological and biomedical ontologies developed, it has become critical to ensure ontology interoperability and the usage of interoperable ontologies for standardized data representation and integration. The suite of web-based Ontoanimal tools (e.g., Ontofox, Ontorat, and Ontobee) support different aspects of extensible ontology development. By summarizing the common features of Ontoanimal and other similar tools, we identified and proposed an "eXtensible Ontology Development" (XOD) strategy and its associated four principles. These XOD principles reuse existing terms and semantic relations from reliable ontologies, develop and apply well-established ontology design patterns (ODPs), and involve community efforts to support new ontology development, promoting standardized and interoperable data and knowledge representation and integration. The adoption of the XOD strategy, together with robust XOD tool development, will greatly support ontology interoperability and robust ontology applications to support data to be Findable, Accessible, Interoperable and Reusable (i.e., FAIR). [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
21. Comparison, alignment, and synchronization of cell line information between CLO and EFO.
- Author
-
Ong, Edison, Sarntivijai, Sirarat, Jupp, Simon, Parkinson, Helen, and Yongqun He
- Subjects
- *
CELL lines , *BIOINFORMATICS , *CELL culture , *ONTOLOGY , *GENOMES - Abstract
Background: The Experimental Factor Ontology (EFO) is an application ontology driven by experimental variables including cell lines to organize and describe the diverse experimental variables and data resided in the EMBL-EBI resources. The Cell Line Ontology (CLO) is an OBO community-based ontology that contains information of immortalized cell lines and relevant experimental components. EFO integrates and extends ontologies from the bio-ontology community to drive a number of practical applications. It is desirable that the community shares design patterns and therefore that EFO reuses the cell line representation from the Cell Line Ontology (CLO). There are, however, challenges to be addressed when developing a common ontology design pattern for representing cell lines in both EFO and CLO. Results: In this study, we developed a strategy to compare and map cell line terms between EFO and CLO. We examined Cellosaurus resources for EFO-CLO cross-references. Text labels of cell lines from both ontologies were verified by biological information axiomatized in each source. The study resulted in the identification 873 EFOCLO aligned and 344 EFO unique immortalized permanent cell lines. All of these cell lines were updated to CLO and the cell line related information was merged. A design pattern that integrates EFO and CLO was also developed. Conclusion: Our study compared, aligned, and synchronized the cell line information between CLO and EFO. The final updated CLO will be examined as the candidate ontology to import and replace eligible EFO cell line classes thereby supporting the interoperability in the bio-ontology domain. Our mapping pipeline illustrates the use of ontology in aiding biological data standardization and integration through the biological and semantics content of cell lines. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. Ontological representation, integration, and analysis of LINCS cell line cells and their cellular responses.
- Author
-
Ong, Edison, Jiangan Xie, Zhaohui Ni, Qingping Liu, Sarntivijai, Sirarat, Yu Lin, Cooper, Daniel, Terryn, Raymond, Stathias, Vasileios, Chung, Caty, Schürer, Stephan, and Yongqun He
- Subjects
- *
CELL lines , *DEPOLYMERIZATION , *APOPTOSIS , *CANCER , *CANCER cells - Abstract
Background: Aiming to understand cellular responses to different perturbations, the NIH Common Fund Library of Integrated Network-based Cellular Signatures (LINCS) program involves many institutes and laboratories working on over a thousand cell lines. The community-based Cell Line Ontology (CLO) is selected as the default ontology for LINCS cell line representation and integration. Results: CLO has consistently represented all 1097 LINCS cell lines and included information extracted from the LINCS Data Portal and ChEMBL. Using MCF 10A cell line cells as an example, we demonstrated how to ontologically model LINCS cellular signatures such as their non-tumorigenic epithelial cell type, three-dimensional growth, latrunculin-A-induced actin depolymerization and apoptosis, and cell line transfection. A CLO subset view of LINCS cell lines, named LINCS-CLOview, was generated to support systematic LINCS cell line analysis and queries. In summary, LINCS cell lines are currently associated with 43 cell types, 131 tissues and organs, and 121 cancer types. The LINCS-CLO view information can be queried using SPARQL scripts. Conclusions: CLO was used to support ontological representation, integration, and analysis of over a thousand LINCS cell line cells and their cellular responses. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
23. Conservation in gene encoding Mycobacterium tuberculosis antigen Rv2660 and a high predicted population coverage of H56 multistage vaccine in South Africa.
- Author
-
Perez-Martinez, Angy P., Ong, Edison, Zhang, Lixin, Marrs, Carl F., He, Yongqun, and Yang, Zhenhua
- Subjects
- *
MYCOBACTERIUM tuberculosis , *VIRUS reactivation , *TUBERCULOSIS prevention , *HLA histocompatibility antigens , *COMPARATIVE genomics - Abstract
H56/AERAS-456 + IC31 (H56), composed of two early secretion proteins, Ag85B and ESAT-6, and a latency associated protein, Rv2660, and the IC31 Intercell adjuvant, is a new fusion subunit vaccine candidate designed to induce immunity against both new infection and reactivation of latent tuberculosis infection. Efficacy of subunit vaccines may be affected by the diversity of vaccine antigens among clinical strains and the extent of recognition by the diverse HLA molecules in the recipient population. Although a previous study showed the conservative nature of Ag85B- and ESAT-6-encoding genes, genetic diversity of Rv2660c that encodes RV2660 is largely unknown. The population coverage of H56 as a whole yet remains to be assessed. The present study was conducted to address these important knowledge gaps. DNA sequence analysis of Rv2660c found no variation among 83 of the 84 investigated clinical strains belonging to four genetic lineages. H56 was predicted to have as high as 99.6% population coverage in the South Africa population using the Immune Epitope Database (IEDB) Population Coverage Tool. Further comparison of H56 population coverage between South African Blacks and Caucasians based on the phenotypic frequencies of binding MHC Class I and Class II supertype alleles found that all of the nine MHC-I and six of eight MHC-II human leukocyte antigen (HLA) supertype alleles analyzed were significantly differentially expressed between the two subpopulations. This finding suggests the presence of race-specific functional binding motifs of MHC-I and MHC-II HLA alleles, which, in turn, highlights the importance of including diverse populations in vaccine clinical evaluation. In conclusion, H56 vaccine is predicted to have a promising population coverage in South Africa; this study demonstrates the utility of integrating comparative genomics and bioinformatics in bridging animal and clinical studies of novel TB vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
24. Identification of New Features from Known Bacterial Protective Vaccine Antigens Enhances Rational Vaccine Design.
- Author
-
Ong, Edison, Wong, Mei U., and Yongqun He
- Subjects
VACCINE effectiveness ,BIOINFORMATICS ,ANTIGEN analysis - Abstract
With many protective vaccine antigens reported in the literature and verified experimentally, how to use the knowledge mined from these antigens to support rational vaccine design and study underlying design mechanism remains unclear. In order to address the problem, a systematic bioinformatics analysis was performed on 291 Gram-positive and Gram-negative bacterial protective antigens with experimental evidence manually curated in the Protegen database. The bioinformatics analyses evaluated included subcellular localization, adhesin probability, peptide signaling, transmembrane α-helix and β-barrel, conserved domain, Clusters of Orthologous Groups, and Gene Ontology functional annotations. Here we showed the critical role of adhesins, along with subcellular localization, peptide signaling, in predicting secreted extracellular or surface-exposed protective antigens, with mechanistic explanations supported by functional analysis. We also found a significant negative correlation of transmembrane α-helix to antigen protectiveness in Gram-positive and Gram-negative pathogens, while a positive correlation of transmembrane β-barrel was observed in Gram-negative pathogens. The commonly less-focused cytoplasmic and cytoplasmic membrane proteins could be potentially predicted with the help of other selection criteria such as adhesin probability and functional analysis. The significant findings in this study can support rational vaccine design and enhance our understanding of vaccine design mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
25. Ontobee: A linked ontology data server to support ontology term dereferencing, linkage, query and integration.
- Author
-
Ong, Edison, Zuoshuang Xiang, Bin Zhao, Yue Liu, Yu Lin, Jie Zheng, Mungall, Chris, Courtot, Mélanie, Ruttenberg, Alan, and Yongqun He
- Published
- 2017
- Full Text
- View/download PDF
26. Combinations of Kinase Inhibitors Protecting Myoblasts against Hypoxia.
- Author
-
Kang, Yunyi, Tierney, Matthew, Ong, Edison, Zhang, Linda, Piermarocchi, Carlo, Sacco, Alessandra, and Paternostro, Giovanni
- Subjects
KINASE inhibitors ,MYOBLASTS ,HYPOXEMIA ,CYCLIN-dependent kinases ,CELL death ,PHARMACOLOGY ,REGRESSION analysis - Abstract
Cell-based therapies to treat skeletal muscle disease are limited by the poor survival of donor myoblasts, due in part to acute hypoxic stress. After confirming that the microenvironment of transplanted myoblasts is hypoxic, we screened a kinase inhibitor library in vitro and identified five kinase inhibitors that protected myoblasts from cell death or growth arrest in hypoxic conditions. A systematic, combinatorial study of these compounds further improved myoblast viability, showing both synergistic and additive effects. Pathway and target analysis revealed CDK5, CDK2, CDC2, WEE1, and GSK3β as the main target kinases. In particular, CDK5 was the center of the target kinase network. Using our recently developed statistical method based on elastic net regression we computationally validated the key role of CDK5 in cell protection against hypoxia. This method provided a list of potential kinase targets with a quantitative measure of their optimal amount of relative inhibition. A modified version of the method was also able to predict the effect of combinations using single-drug response data. This work is the first step towards a broadly applicable system-level strategy for the pharmacology of hypoxic damage. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
27. A Scalable Method for Molecular Network Reconstruction Identifies Properties of Targets and Mutations in Acute Myeloid Leukemia.
- Author
-
Ong, Edison, Szedlak, Anthony, Kang, Yunyi, Smith, Peyton, Smith, Nicholas, McBride, Madison, Finlay, Darren, Vuori, Kristiina, Mason, James, Ball, Edward D., Piermarocchi, Carlo, and Paternostro, Giovanni
- Subjects
- *
SYSTEMS biology , *MOLECULAR biology , *SCIENTISTS , *DNA microarrays , *RNA , *GENE expression - Abstract
A key aim of systems biology is the reconstruction of molecular networks. We do not yet, however, have networks that integrate information from all datasets available for a particular clinical condition. This is in part due to the limited scalability, in terms of required computational time and power, of existing algorithms. Network reconstruction methods should also be scalable in the sense of allowing scientists from different backgrounds to efficiently integrate additional data. We present a network model of acute myeloid leukemia (AML). In the current version (AML 2.1), we have used gene expression data (both microarray and RNA-seq) from 5 different studies comprising a total of 771 AML samples and a protein-protein interactions dataset. Our scalable network reconstruction method is in part based on the well-known property of gene expression correlation among interacting molecules. The difficulty of distinguishing between direct and indirect interactions is addressed by optimizing the coefficient of variation of gene expression, using a validated gold-standard dataset of direct interactions. Computational time is much reduced compared to other network reconstruction methods. A key feature is the study of the reproducibility of interactions found in independent clinical datasets. An analysis of the most significant clusters, and of the network properties (intraset efficiency, degree, betweenness centrality, and PageRank) of common AML mutations demonstrated the biological significance of the network. A statistical analysis of the response of blast cells from 11 AML patients to a library of kinase inhibitors provided an experimental validation of the network. A combination of network and experimental data identified CDK1, CDK2, CDK4, and CDK6 and other kinases as potential therapeutic targets in AML. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
28. Prediction of kinase inhibitor response using activity profiling, in vitro screening, and elastic net regression.
- Author
-
Tran, Trish P., Ong, Edison, Hodges, Andrew P., Paternostro, Giovanni, and Piermarocchi, Carlo
- Subjects
- *
KINASE inhibitors , *CANCER treatment , *DRUG efficacy , *REGRESSION analysis , *CANCER genetics - Abstract
Background Many kinase inhibitors have been approved as cancer therapies. Recently, libraries of kinase inhibitors have been extensively profiled, thus providing a map of the strength of action of each compound on a large number of its targets. These profiled libraries define drug-kinase networks that can predict the effectiveness of untested drugs and elucidate the roles of specific kinases in different cellular systems. Predictions of drug effectiveness based on a comprehensive network model of cellular signalling are difficult, due to our partial knowledge of the complex biological processes downstream of the targeted kinases. Results We have developed the Kinase Inhibitors Elastic Net (KIEN) method, which integrates information contained in drug-kinase networks with in vitro screening. The method uses the in vitro cell response of single drugs and drug pair combinations as a training set to build linear and nonlinear regression models. Besides predicting the effectiveness of untested drugs, the KIEN method identifies sets of kinases that are statistically associated to drug sensitivity in a given cell line. We compared different versions of the method, which is based on a regression technique known as elastic net. Data from two-drug combinations led to predictive models, and we found that predictivity can be improved by applying logarithmic transformation to the data. The method was applied to the A549 lung cancer cell line, and we identified specific kinases known to have an important role in this type of cancer (TGFBR2, EGFR, PHKG1 and CDK4). A pathway enrichment analysis of the set of kinases identified by the method showed that axon guidance, activation of Rac, and semaphorin interactions pathways are associated to a selective response to therapeutic intervention in this cell line. Conclusions We have proposed an integrated experimental and computational methodology, called KIEN, that identifies the role of specific kinases in the drug response of a given cell line. The method will facilitate the design of new kinase inhibitors and the development of therapeutic interventions with combinations of many inhibitors. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
29. Identification of Drug Combinations Containing Imatinib for Treatment of BCR-ABL+ Leukemias.
- Author
-
Kang, Yunyi, Hodges, Andrew, Ong, Edison, Roberts, William, Piermarocchi, Carlo, and Paternostro, Giovanni
- Subjects
LEUKEMIA treatment ,IMATINIB ,PROTEIN-tyrosine kinase inhibitors ,HEMATOLOGY ,MEDICAL sciences ,FIBROBLASTS - Abstract
The BCR-ABL translocation is found in chronic myeloid leukemia (CML) and in Ph+ acute lymphoblastic leukemia (ALL) patients. Although imatinib and its analogues have been used as front-line therapy to target this mutation and control the disease for over a decade, resistance to the therapy is still observed and most patients are not cured but need to continue the therapy indefinitely. It is therefore of great importance to find new therapies, possibly as drug combinations, which can overcome drug resistance. In this study, we identified eleven candidate anti-leukemic drugs that might be combined with imatinib, using three approaches: a kinase inhibitor library screen, a gene expression correlation analysis, and literature analysis. We then used an experimental search algorithm to efficiently explore the large space of possible drug and dose combinations and identified drug combinations that selectively kill a BCR-ABL+ leukemic cell line (K562) over a normal fibroblast cell line (IMR-90). Only six iterations of the algorithm were needed to identify very selective drug combinations. The efficacy of the top forty-nine combinations was further confirmed using Ph+ and Ph- ALL patient cells, including imatinib-resistant cells. Collectively, the drug combinations and methods we describe might be a first step towards more effective interventions for leukemia patients, especially those with the BCR-ABL translocation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
30. Identification of Mycobacterium tuberculosis Antigens with Vaccine Potential Using a Machine Learning-Based Reverse Vaccinology Approach.
- Author
-
Teahan, Blaine, Ong, Edison, and Yang, Zhenhua
- Subjects
MYCOBACTERIUM tuberculosis ,TUBERCULOSIS vaccines ,CAUSES of death ,INFECTION ,VACCINE effectiveness ,TEAM learning approach in education - Abstract
Tuberculosis (TB) is the leading cause of death of any single infectious agent, having led to 1.4 million deaths in 2019 alone. Moreover, an estimated one-quarter of the global population is latently infected with Mycobacterium tuberculosis (MTB), presenting a huge pool of potential future disease. Nonetheless, the only currently licensed TB vaccine fails to prevent the activation of latent TB infections (LTBI). These facts together illustrate the desperate need for a more effective TB vaccine strategy that can prevent both primary infection and the activation of LTBI. In this study, we employed a machine learning-based reverse vaccinology approach to predict the likelihood that each protein within the proteome of MTB laboratory reference strain H37Rv would be a protective antigen (PAg). The proteins predicted most likely to be a PAg were assessed for their belonging to a protein family of previously established PAgs, the relevance of their biological processes to MTB virulence and latency, and finally the immunogenic potential that they may provide in terms of the number of promiscuous epitopes within each. This study led to the identification of 16 proteins with the greatest vaccine potential for further in vitro and in vivo studies. It also demonstrates the value of computational methods in vaccine development. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
31. Water for the barrios (field trials of the Malaysian 'Unimade' handpump in the Philippines)
- Author
-
Timm, Mark, Ong, Edison Dy, and Toomey, Gerry
- Subjects
Business ,Business, international - Published
- 1988
32. Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development.
- Author
-
Ong, Edison, He, Yongqun, and Yang, Zhenhua
- Subjects
- *
ANTIGENS , *MYCOBACTERIUM tuberculosis , *VACCINES , *MYCOBACTERIA , *EPITOPES , *INFECTION - Abstract
Tuberculosis (TB) is the leading infectious cause of death worldwide and claimed over 1.6 million lives in 2017. Furthermore, one-third of the world population is estimated to be latently infected with Mycobacterium tuberculosis (MTB). A safe and effective MTB vaccine that can prevent both the primary infection and the reactivation of latent tuberculosis infection (LTBI), and that can protect against all forms of TB in adults and adolescents is urgently needed. In this study, using computational approaches, we predicted the capacity of the epitopes to be presented by the HLA molecules for ten MTB protein antigens (Mtb39a, Mtb32a, Ag85B, ESAT-6, TB10.4, Rv2660, Rv2608, Rv3619, Rv3620, and Rv1813) constituting five MTB subunit vaccines (M72, H1, H4, H56, and ID93) that are currently in clinical trials. We also assessed the promiscuity of the predicted epitopes based on a reference set of alleles and supertype alleles, and estimated the population coverage of the ten antigens in three high TB burden countries (China, India, and South Africa). Among the ten antigens evaluated, Rv2608 was found to have the highest number of promiscuous epitopes predicted to bind the most MHC-I and MHC-II supertype alleles, highest predicted immunogenicity, and the broadest population coverage in three high burden countries. Between the two latency-related antigens (Rv1813 and Rv2660), Rv1813 was predicted to have a better epitope diversity and promiscuity, immunogenicity, and population coverage. As a result, the ID93 vaccine consisted of Rv2608, Rv1813, Rv3619, and Rv3620 was predicted to have the best potential for preventing both active and latent TB infection. Our results highlighted the importance and usefulness of a systematic and comprehensive assessment of protein antigens using computational approaches in MTB vaccine development. • Computational analysis for ten protein antigens constituting five MTB subunit in clinical trials. • Rv2608 was predicted to be the best non-latency-related protein antigen. • Rv1813 was predicted to be the better latency-related protein antigen compared to Rv2660. • ID93 vaccine, which includes Rv2608 and Rv1813, was expected to be the best multistage MTB vaccine. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.